US Stock MarketDetailed Quotes

Atea Pharmaceuticals (AVIR)

Watchlist
  • 5.320
  • +0.010+0.19%
Close Sep 14 16:00 ET
426.69MMarket Cap-2.56P/E (TTM)

About Atea Pharmaceuticals Company

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Company Profile

SymbolAVIR
Company NameAtea Pharmaceuticals
Listing DateOct 30, 2020
Issue Price24.00
ISINUS04683R1068
Founded2012
CEODr. Jean-Pierre Sommadossi,PhD
MarketNASDAQ
Employees55
Fiscal Year Ends12-31
Address225 Franklin Street,Suite 2100
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02110
Phone1-857-284-8891

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jean-Pierre Sommadossi,PhD
  • President, Chief Executive Officer and Chairman of the Board
  • 3.40M
  • Andrea J. Corcoran
  • Chief Financial Officer, Secretary, Executive Vice President, Legal
  • 1.69M
  • Wayne Foster
  • Chief Accounting Officer and Executive Vice President, Finance
  • --
  • John Vavricka
  • Chief Commercial Officer
  • 1.22M
  • Dr. Maria Arantxa Horga, M.D.
  • Chief Medical Officer
  • 1.59M
  • Dr. Janet Hammond, M.D.,PhD
  • Chief Development Officer
  • 1.77M
  • Barbara G. Duncan
  • Independent Director
  • 256.90K
  • Franklin M. Berger, C.F.A.
  • Lead Independent Director
  • 282.90K
  • Bruno Lucidi
  • Independent Director
  • 249.40K
  • Arthur Kirsch
  • Independent Director
  • 415.33K
  • Dr. Polly A. Murphy, D.V.M.,PhD
  • Independent Director
  • 251.90K
  • Dr. Jerome M. Ada M.D.
  • Independent Director
  • 366.90K
  • Dr. Howard Berman, PhD
  • Independent Director
  • 407.11K
  • Dr. Bruce Polsky, M.D.
  • Independent Director
  • 249.40K
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla Show More